Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in ADCT held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Redmile Group, LLC | 15.5M | $58.0M | -1.3% | 12.163% | 3.84% |
| 2 | TCG Crossover Management, LLC | 11.4M | $42.7M | 0.0% | 8.955% | 1.22% |
| 3 | Prosight Management, LP | 8.3M | $31.1M | -2.1% | 6.526% | 5.10% |
| 4 | BlackRock, Inc. | 6.3M | $23.4M | +15.2% | 4.915% | 0.00% |
| 5 | EVENTIDE ASSET MANAGEMENT, LLC | 5.7M | $21.4M | +69.5% | 4.483% | 0.35% |
| 6 | Nantahala Capital Management, LLC | 5.6M | $21.0M | +2.2% | 4.401% | 1.08% |
| 7 | MORGAN STANLEY | 3.8M | $14.3M | +1.1% | 2.998% | 0.00% |
| 8 | Point72 Asset Management, L.P. | 3.4M | $12.8M | -32.0% | 2.680% | 0.02% |
| 9 | GOLDMAN SACHS GROUP INC | 1.7M | $6.2M | +0.7% | 1.300% | 0.00% |
| 10 | STATE STREET CORP | 1.6M | $5.9M | +11.3% | 1.232% | 0.00% |
| 11 | BANK OF AMERICA CORP /DE/ | 1.3M | $5.0M | +2.0% | 1.042% | 0.00% |
| 12 | ORBIMED ADVISORS LLC | 1.3M | $4.9M | -77.4% | 1.036% | 0.10% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.2M | $4.5M | +20.8% | 0.946% | 0.00% |
| 14 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.0M | $3.9M | β | 0.812% | 0.00% |
| 15 | PLATINUM INVESTMENT MANAGEMENT LTD | 991K | $3.7M | 0.0% | 0.779% | 0.94% |
| 16 | BNP PARIBAS ARBITRAGE, SA | 860K | $3.2M | +3.6% | 0.676% | 0.00% |
| 17 | PANAGORA ASSET MANAGEMENT INC | 691K | $2.6M | +16.3% | 0.543% | 0.01% |
| 18 | Blue Owl Capital Holdings LP | 734K | $2.6M | 0.0% | 0.577% | 0.70% |
| 19 | TWO SIGMA INVESTMENTS, LP | 668K | $2.5M | +459.2% | 0.525% | 0.00% |
| 20 | NORTHERN TRUST CORP | 552K | $2.1M | +26.2% | 0.434% | 0.00% |
| 21 | Voleon Capital Management LP | 514K | $1.9M | +10.7% | 0.404% | 0.04% |
| 22 | UBS Group AG | 459K | $1.7M | +113.2% | 0.361% | 0.00% |
| 23 | SCHRODER INVESTMENT MANAGEMENT GROUP | 419K | $1.5M | 0.0% | 0.329% | 0.00% |
| 24 | CITADEL ADVISORS LLC | 400K | $1.5M | +28.8% | 0.314% | 0.00% |
| 25 | RENAISSANCE TECHNOLOGIES LLC | 299K | $1.1M | β | 0.235% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in ADCT β a direct measure of their conviction.
Filings activity in ADCT during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new ADCT position in Q1 2026
Institutions that fully closed their ADCT position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 115 | +0.9% | 199.99% | +0.00 pp | $297M | +2.2% |
| Q4 2025 | 114 | +9.6% | 199.99% | +0.00 pp | $291M | +7.6% |
| Q3 2025 | 104 | +20% | 199.99% | +63.49 pp | $270M | +48% |
| Q2 2025 | 87 | +2.4% | 136.50% | +78.82 pp | $182M | +137% |
| Q1 2025 | 85 | +0.0% | 57.68% | 26.16 pp | $77M | 31% |
| Q4 2024 | 85 | +7.6% | 83.84% | 45.05 pp | $112M | 35% |
| Q3 2024 | 79 | +5.3% | 128.89% | +5.99 pp | $172M | +4.9% |
| Q2 2024 | 75 | β | 122.90% | β | $164M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ADCT stock.
Based on Q1 2026 13F filings, institutional ownership of ADC Therapeutics S.A. stands at 200.0%, held across 115 reporting institutions.
Redmile Group, LLC is the largest reported institutional holder of ADCT, with approximately 15,470,502 shares worth $0.06B as of Q1 2026.
Yes β 4 widely-followed marquee investors appear among the top 25 institutional holders of ADCT, including Point72 Asset Management, L.P., TWO SIGMA INVESTMENTS, LP, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC.
Our composite Smart Money Score for ADCT is 61 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
20 institutions opened new positions in ADCT during Q1 2026, while 19 fully exited. 71 added to existing positions and 22 trimmed.
ADCT institutional ownership rose by 0.00 percentage points quarter-over-quarter, with a net change of +1 holders.
The top 10 institutions account for 79.7% of all reported 13F value in ADCT, and the top 25 account for 94.1%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
ADC Therapeutics S.A. (ADCT) Institutional Ownership